BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33363074)

  • 1. Use of Social Media as a Tool to Reduce Antibiotic Usage: A Neglected Approach to Combat Antimicrobial Resistance in Low and Middle Income Countries.
    Acharya KP; Subedi D
    Front Public Health; 2020; 8():558576. PubMed ID: 33363074
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the factors that contribute to the successful implementation of antimicrobial resistance interventions: a comparison of high-income and low-middle-income countries.
    Graells T; Lambraki IA; Cousins M; Léger A; Henriksson PJG; Troell M; Carson CA; Parmley EJ; Majowicz SE; Wernli D; Jørgensen PS
    Front Public Health; 2023; 11():1230848. PubMed ID: 37900049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.
    Mahadi AR
    Front Public Health; 2021; 9():770593. PubMed ID: 34976929
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis.
    Ayobami O; Brinkwirth S; Eckmanns T; Markwart R
    Emerg Microbes Infect; 2022 Dec; 11(1):443-451. PubMed ID: 35034585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing bespoke antimicrobials to combat antimicrobial resistance in low- and middle-income countries: A critical appraisal of clinical utility in the elderly.
    MohanaSundaram A; Sathanantham ST; Sah R; Apostolopoulos V
    Maturitas; 2023 Apr; 170():74-75. PubMed ID: 36494242
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic resistance in low- and middle-income countries: current practices and its global implications.
    Al Meslamani AZ
    Expert Rev Anti Infect Ther; 2023; 21(12):1281-1286. PubMed ID: 37804134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review.
    Luchen CC; Chibuye M; Spijker R; Simuyandi M; Chisenga C; Bosomprah S; Chilengi R; Schultsz C; Mende DR; Harris VC
    PLoS Med; 2023 Jun; 20(6):e1004235. PubMed ID: 37368871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries.
    Lim C; Ashley EA; Hamers RL; Turner P; Kesteman T; Akech S; Corso A; Mayxay M; Okeke IN; Limmathurotsakul D; van Doorn HR
    Clin Microbiol Infect; 2021 Oct; 27(10):1391-1399. PubMed ID: 34111583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility.
    Sharma A; Singh A; Dar MA; Kaur RJ; Charan J; Iskandar K; Haque M; Murti K; Ravichandiran V; Dhingra S
    J Infect Public Health; 2022 Feb; 15(2):172-181. PubMed ID: 34972026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia.
    Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C
    Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the most effective community-based antimicrobial stewardship interventions in low- and middle-income countries? A narrative review.
    Lam TT; Dang DA; Tran HH; Do DV; Le H; Negin J; Jan S; Marks GB; Nguyen TA; Fox GJ; Beardsley J
    J Antimicrob Chemother; 2021 Apr; 76(5):1117-1129. PubMed ID: 33491090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future.
    Godman B; Haque M; McKimm J; Abu Bakar M; Sneddon J; Wale J; Campbell S; Martin AP; Hoxha I; Abilova V; Anand Paramadhas BD; Mpinda-Joseph P; Matome M; de Lemos LLP; Sefah I; Kurdi A; Opanga S; Jakupi A; Saleem Z; Hassali MA; Kibuule D; Fadare J; Bochenek T; Rothe C; Furst J; Markovic-Pekovic V; Bojanić L; Schellack N; Meyer JC; Matsebula Z; Phuong TNT; Thanh BN; Jan S; Kalungia A; Mtapuri-Zinyowera S; Sartelli M; Hill R
    Curr Med Res Opin; 2020 Feb; 36(2):301-327. PubMed ID: 31794332
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacterial Resistance in Surgical Infections in Low-Resource Settings.
    Rickard J
    Surg Infect (Larchmt); 2020 Aug; 21(6):509-515. PubMed ID: 32380936
    [No Abstract]   [Full Text] [Related]  

  • 15. Global surveillance of antimicrobial resistance and hypervirulence in Klebsiella pneumoniae from LMICs: An in-silico approach.
    Silvester R; Madhavan A; Kokkat A; Parolla A; B M A; M H; Abdulla MH
    Sci Total Environ; 2022 Jan; 802():149859. PubMed ID: 34464800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries.
    Gandra S; Alvarez-Uria G; Turner P; Joshi J; Limmathurotsakul D; van Doorn HR
    Clin Microbiol Rev; 2020 Sep; 33(3):. PubMed ID: 32522747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global trend of antimicrobial resistance in common bacterial pathogens in response to antibiotic consumption.
    Hou J; Long X; Wang X; Li L; Mao D; Luo Y; Ren H
    J Hazard Mater; 2023 Jan; 442():130042. PubMed ID: 36182890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic knowledge, attitudes and practices: new insights from cross-sectional rural health behaviour surveys in low-income and middle-income South-East Asia.
    Haenssgen MJ; Charoenboon N; Zanello G; Mayxay M; Reed-Tsochas F; Lubell Y; Wertheim H; Lienert J; Xayavong T; Khine Zaw Y; Thepkhamkong A; Sithongdeng N; Khamsoukthavong N; Phanthavong C; Boualaiseng S; Vongsavang S; Wibunjak K; Chai-In P; Thavethanutthanawin P; Althaus T; Greer RC; Nedsuwan S; Wangrangsimakul T; Limmathurotsakul D; Elliott E; Ariana P
    BMJ Open; 2019 Aug; 9(8):e028224. PubMed ID: 31434769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
    Browne AJ; Chipeta MG; Haines-Woodhouse G; Kumaran EPA; Hamadani BHK; Zaraa S; Henry NJ; Deshpande A; Reiner RC; Day NPJ; Lopez AD; Dunachie S; Moore CE; Stergachis A; Hay SI; Dolecek C
    Lancet Planet Health; 2021 Dec; 5(12):e893-e904. PubMed ID: 34774223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of civil society organizations (CSOs) in antimicrobial resistance (AMR) mitigation efforts in low- and middle-income countries: A report from India.
    Ranganathan R; Ranjalkar J
    J Infect Public Health; 2023 Dec; 16 Suppl 1():125-128. PubMed ID: 37973495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.